# Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1

> **NCT00032968** · PHASE3 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 341 (—)

## Conditions studied

- Heroin Dependence
- Morphine Dependence
- Substance Withdrawal Syndrome

## Interventions

- **DRUG:** Buprenorphine/naloxone

## Key facts

- **NCT ID:** NCT00032968
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** 341 (—)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00032968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00032968, "Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00032968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*